Analyser av Prolight Diagnostics

Prolight: Commercial prototype marks an important milestone towards upcoming studies - Emergers

The arrival of the first commercial prototype instruments for Prolight’s Psyros Point of Care (POC) system marks an important development mi...

Prolight continues to make progress with its proprietary Psyros platform, with a pre-validation study, including fresh blood samples from 12...

Supported by the latest troponin data generated from whole blood samples on the final commercial cartridge design, Prolight is now ready to ...

Prolight’s report for Q1’24 did not reveal any particular surprises.

Mangold Insight inleder bevakning av medicinteknik-bolaget Prolight Diagnostics med rekommendationen Köp.

There has been a somewhat mixed news flow from Prolight after the close of Q1’24.

There has been a somewhat mixed news flow from Prolight after the close of Q1’24.

With proof-of-performance for its proprietary digital technique for detection of high-sensitive biomarkers even in whole blood, Prolight has...

Having already achieved proof-of-performance for its proprietary digital technique for detection of high-sensitive biomarkers in low concent...